Abstract
Recently, the fluorescence techniques have become increasingly important in medical diagnostics. Moreover, there is a growing need to introduce cost-effective and no time-consuming techniques for the investigation of various fluorophores in humans and animals with diabetes mellitus. In the studied literature, the newly diagnosis of diabetes mellitus and, subsequently, the risk of developing diabetes complications are reported to be correlated with the production of serum fluorophores pentosidine and retinol binding protein. As far as we are aware, there has been no study on the simultaneous fluorescence evaluation of pentosidine and retinol binding protein in biological fluids obtained from animals. In the present study, the emission intensity and levels of serum pentosidine and retinol binding protein were monitored in both healthy rats and rats with streptozotocin-induced diabetes. The results showed that the height of the peak at ~382 nm attributed to the presence of pentosidine in the serum, and the height of the peak at ~465 nm attributed to retinol binding protein in the serum were significantly higher in rats with streptozotocin-induced diabetes compared to healthy control rats. Also, their contributions to the total fluorescence of serum were significantly higher in rats with streptozotocin-induced diabetes compared to healthy control rats. Thus, fluorescence spectroscopy might be a reliable and useful technique that can be successfully applied in the evaluation and monitoring of serum pentosidine and retinol binding protein in both healthy rats and rats with streptozotocin-induced diabetes.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
O’Neill, D.G., Gostelow, R., Orme, C., et al.: Epidemiology of Diabetes Mellitus among 193,435 cats attending primary care veterinary practices in England. J. Vet. Int. Med. 30(4), 964–972 (2016). https://doi.org/10.1111/jvim.14365
Cho, N.H., Shaw, J.E., Karuranga, S., et al.: IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res. Clin. Pract. 138, 271–281 (2018). https://doi.org/10.1016/j.diabres.2018.02.023
Kerkeni, M., Saïdi, A., Bouzidi, H., et al.: Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients. Diab. Vasc. Dis. Res. 10(3), 239–245 (2013). https://doi.org/10.1177/1479164112460253
Ram, J., Snehalatha, C., Selvam, S., et al.: Retinol binding protein-4 predicts incident diabetes in Asian Indian men with prediabetes. BioFactors 41(3), 160–165 (2015). https://doi.org/10.1002/biof.1209
Rhee, E.J., Plutzky, J.: Retinoid Metabolism and Diabetes Mellitus. Diabetes Metab. J. 36(3), 167–180 (2012). https://doi.org/10.4093/dmj.2012.36.3.167
Tanaka, M.: Relationship between urinary pentosidine concentration and vascular complications in type 2 diabetic patients. J Diabetes Metab. 7, 640 (2016). https://doi.org/10.4172/2155-6156.1000640
Cabré, A., Lázaro, I., Girona, J., et al.: Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes. J. Intern. Med. 262(4), 496–503 (2007)
Novery, E., Susanah, S., Rachmadi, D.: The Correlation of urine retinol binding protein-4 and serum HbA1c with glomerular filtration rate in type 1 (insulin-dependent) diabetic children: a perspective on the duration of diabetes. Open J. Pediatrics 05(2), 134–140 (2015). https://doi.org/10.4236/ojped.2015.52020
Grandhee, S.K., Monnier, V.M.: Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors. J. Biol. Chem. 266(18), 11649–11653 (1991)
Sternberg, M., M’bemba, J., Urios, P., et al.: Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6 years after punch-biopsy. Clin. Biochem. 49(3), 225–231 (2016). https://doi.org/10.1016/j.clinbiochem.2015.10.011
Rabbani, N., Thornalley, P.J.: Hidden complexities in the measurement of fructosyl-lysine and advanced glycation end products for risk prediction of vascular complications of diabetes. Diabetes 64(1), 9–11 (2015). https://doi.org/10.2337/db14-1516
Requena, J.R., Price, D.L., Thorpe, S.R., Baynes, J.W.: Measurement of pentosidine in biological samples. Aging Methods Protoc. 38, 209–217 (2000). https://doi.org/10.1385/1-59259-070-5:209
Tanumihardjo, S.A.: Assessing vitamin A status: past, present and future. J. Nutr. 134(1), 290S–293S (2004)
Raghu, P., Sivakumar, B.: Interactions amongst plasma retinol-binding protein, transthyretin and their ligands: implications in vitamin A homeostasis and transthyretin amyloidosis. Biochimica et Biophysica Acta (BBA)—Proteins Proteomics 1703(1), 1–9 (2004). https://doi.org/10.1016/j.bbapap.2004.09.023
Silvaroli, J.A., Arne, J.M., Chelstowska, S., et al.: Ligand binding induces conformational changes in human cellular Retinol-binding Protein 1 (RETINOL BINDING PROTEIN 1) revealed by atomic resolution crystal structures. J. Biol. Chem. 29(16), 8528–8540 (2016). https://doi.org/10.1074/jbc.M116.714535
Berry, D.C., Croniger, C.M., Ghyselinck, N.B., et al.: Transthyretin blocks retinol uptake and cell signaling by the holo-retinol-binding protein receptor STRA6. Mol. Cell. Biol. 32(19), 3851–3859 (2012). https://doi.org/10.1128/MCB.00775-12
Monaco, H.L.: The transthyretin-retinol-binding protein complex. Biochimica et Biophysica Acta (BBA)—Protein Struct. Mol. Enzymol. 1482(1–2), 65–72 (2000). https://doi.org/10.1016/s0167-4838(00)00140-0
Futterman, S., Swanson, D., Kalina, R.E.: A new, rapid fluorometric determination of retinol in serum. Invest Ophthalmol. 14(2), 125–130 (1975)
Kawaguchi, R., Zhong, M., Sun, H.: Real-time analyses of retinol transport by the membrane receptor of plasma retinol binding protein. J. Visualized Exp. JoVE 71, e50169 (2013). https://doi.org/10.3791/50169
Kraft, R., Herndon, D.N., Kulp, G.A. et al.: Retinol binding protein: marker for insulin resistance and inflammation postburn? JPEN. J. Parenteral Enteral Nutr. 35(6) (2011). https://doi.org/10.1177/0148607111413901
Klisić, A., Kavarić, N., Bjelaković, B., et al.: The association between retinol-binding protein 4 and cardiovascular risk score is mediated by waist circumference in overweight/obese adolescent girls. Acta Clin. Croat. 56(1), 92–98 (2017). https://doi.org/10.20471/acc.2017.56.01.14
Kim, Y.S., Kim, N.H., Lee, S.W., et al.: Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats. Eur. J. Pharmacol. 569(3), 171–179 (2007)
Séro, L., Sanguinet, L., Blanchard, P., et al.: Tuning a 96-well microtiter plate fluorescence-based assay to identify AGE inhibitors in crude plant extracts. Molecules 18(11), 14320–14339 (2013). https://doi.org/10.3390/molecules181114320
Takahashi, M., Oikawa, M., Nagano, A.: Effect of age and menopause on serum concentrations of pentosidine, an advanced glycation end product. J Gerontol A 55(3), M137–M140 (2000). https://doi.org/10.1093/gerona/55.3.M137
Olar, L.E., Ciobanu, D.M., Matei, F., Papuc, I.: The assessment of fluorophores advanced glycation end products-to-kynurenine ratio in healthy and diabetic rats and humans. Studia. UBB Chemia. 63(1), 37–53 (2018). https://doi.org/10.24193/subbchem.2018.1.03
Sugiyama, S., Miyata, T., Ueda, Y., et al.: Plasma levels of pentosidine in diabetic patients: an advanced glycation end product. J. Am. Soc. Nephrol. 9(9), 1681–1688 (1998)
Machowska, A., Sun, J., Qureshi, A.R et al. Plasma pentosidine and its association with mortality in patients with chronic kidney disease. PLoS one 4; 11(10): e0163826 (2016). https://doi.org/10.1371/journal.pone.0163826
Chang, Y.H., Lin, K.D., Wang, C.L., et al.: Elevated serum retinol-binding protein 4 concentrations are associated with renal dysfunction and uric acid in type 2 diabetic patients. Diabetes Metab. Res. Rev. 24(8), 629–634 (2008). https://doi.org/10.1002/dmrr.894
Abahusain, M.A., Wright, J., Dickerson, J.W.: Retinol, alpha-tocopherol and carotenoids in diabetes. Eur. J. Clin. Nutr. 53(8), 630–635 (1999)
Tuitoek, P.J., Ziari, S., Tsin, A.T., et al.: Streptozotocin-induced diabetes in rats is associated with impaired metabolic availability of vitamin A (retinol). Br. J. Nutr. 75(4), 615–622 (1996)
Acknowledgements
The work was supported by an internal grant (4994/3/08.03.2016) financed by the Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca.
Conflict of Interest
The authors declare that they have no potential conflict of interest relevant to this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this paper
Cite this paper
Ciobanu, D.M., Olar, L.E., Ştefan, R., Roman, G., Papuc, I. (2019). Spectrofluorimetric Characterization of Serum Pentosidine and Retinol Binding Protein in Healthy Rats and Rats with Streptozotocin-Induced Diabetes. In: Vlad, S., Roman, N. (eds) 6th International Conference on Advancements of Medicine and Health Care through Technology; 17–20 October 2018, Cluj-Napoca, Romania. IFMBE Proceedings, vol 71. Springer, Singapore. https://doi.org/10.1007/978-981-13-6207-1_1
Download citation
DOI: https://doi.org/10.1007/978-981-13-6207-1_1
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-6206-4
Online ISBN: 978-981-13-6207-1
eBook Packages: EngineeringEngineering (R0)